Global Thyroid Cancer Diagnostic Market to reach USD 3.7 billion by 2027

Global Thyroid Cancer Diagnostic Market Size study, by Type (Papillary carcinoma, Follicular carcinoma, Others), by Technique (Blood test, Imaging, Biopsy, Others), by End-Use (Hospital laboratories, Cancer diagnostic centers, Research institutes) and Regional Forecasts 2020-2027
Product Code:  HALMD_76173799
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Thyroid Cancer Diagnostic Market, by Region, 2018-2027 (USD Billion)
1.2.2.	Thyroid Cancer Diagnostic Market, by Type, 2018-2027 (USD Billion)
1.2.3.	Thyroid Cancer Diagnostic Market, by Technique, 2018-2027 (USD Billion)
1.2.4.	Thyroid Cancer Diagnostic Market, by End-Use, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Thyroid Cancer Diagnostic Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Thyroid Cancer Diagnostic Market Dynamics	
3.1.	Thyroid Cancer Diagnostic Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Thyroid Cancer Diagnostic Market: Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Thyroid Cancer Diagnostic Market, by Type 
5.1.	Market Snapshot 
5.2.	Global Thyroid Cancer Diagnostic Market by Type, Performance - Potential Analysis
5.3.	Global Thyroid Cancer Diagnostic Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4.	Thyroid Cancer Diagnostic Market, Sub Segment Analysis
5.4.1.	Papillary carcinoma
5.4.2.	Follicular carcinoma
5.4.3.	Others
Chapter 6.	Global Thyroid Cancer Diagnostic Market, by Technique          
6.1.	Market Snapshot 
6.2.	Global Thyroid Cancer Diagnostic Market by Technique, Performance - Potential Analysis
6.3.	Global Thyroid Cancer Diagnostic Market Estimates & Forecasts by Technique 2017-2027 (USD Billion)
6.4.	Thyroid Cancer Diagnostic Market, Sub Segment Analysis
6.4.1.	Blood test
6.4.2.	Imaging
6.4.3.	Biopsy
6.4.4.	Others
Chapter 7.	Global Thyroid Cancer Diagnostic Market, by End-Use
7.1.	Market Snapshot 
7.2.	Global Thyroid Cancer Diagnostic Market by End-Use - Potential Analysis
7.3.	Global Thyroid Cancer Diagnostic Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)
7.4.	Thyroid Cancer Diagnostic Market, Sub Segment Analysis
7.4.1.	Hospital laboratories
7.4.2.	Cancer diagnostic centers
7.4.3.	Research institutes
Chapter 8.	Global Thyroid Cancer Diagnostic Market, Regional Analysis
8.1.	Thyroid Cancer Diagnostic Market, Regional Market Snapshot 
8.2.	North America Thyroid Cancer Diagnostic Market 
8.2.1.	U.S. Thyroid Cancer Diagnostic Market
8.2.1.1.	Type breakdown estimates & forecasts, 2017-2027
8.2.1.2.	Technique breakdown estimates & forecasts, 2017-2027
8.2.1.3.	End-Use breakdown estimates & forecasts, 2017-2027
8.2.2.	Canada Thyroid Cancer Diagnostic Market
8.3.	Europe Thyroid Cancer Diagnostic Market Snapshot
8.3.1.	U.K. Thyroid Cancer Diagnostic Market 
8.3.2.	Germany Thyroid Cancer Diagnostic Market
8.3.3.	France Thyroid Cancer Diagnostic Market
8.3.4.	Spain Thyroid Cancer Diagnostic Market
8.3.5.	Italy Thyroid Cancer Diagnostic Market
8.3.6.	Rest of Europe Thyroid Cancer Diagnostic Market
8.4.	Asia-Pacific Thyroid Cancer Diagnostic Market Snapshot
8.4.1.	China Thyroid Cancer Diagnostic Market 
8.4.2.	India Thyroid Cancer Diagnostic Market 
8.4.3.	Japan Thyroid Cancer Diagnostic Market
8.4.4.	Australia Thyroid Cancer Diagnostic Market
8.4.5.	South Korea Thyroid Cancer Diagnostic Market
8.4.6.	Rest of Asia Pacific Thyroid Cancer Diagnostic Market
8.5.	Latin America Thyroid Cancer Diagnostic Market Snapshot
8.5.1.	Brazil Thyroid Cancer Diagnostic Market
8.5.2.	Mexico Thyroid Cancer Diagnostic Market
8.6.	Rest of The World Thyroid Cancer Diagnostic Market
Chapter 9.	Competitive Intelligence
9.1.	Top Market Strategies
9.2.	Company Profiles
9.2.1.	F. Hoffmann-La Roche Ltd.
9.2.1.1.	Key Information
9.2.1.2.	Overview
9.2.1.3.	Financial (Subject to Data Availability)
9.2.1.4.	Product Summary
9.2.1.5.	Recent Developments
9.2.2.	Abbott Laboratories
9.2.3.	Thermo Fisher Scientific, Inc.
9.2.4.	General Electric
9.2.5.	Siemens Healthcare GmbH
9.2.6.	Bio-Rad Laboratories, Inc.
9.2.7.	Toshiba Corporation
9.2.8.	Koninklijke Philips N.V.
9.2.9.	Agilent Technologies, Inc.
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.2.	Research Attributes
10.3.	Research Assumption

Global Thyroid Cancer Diagnostic Market is valued approximately at USD 2.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2020-2027. Thyroid cancer is a sort of cancer that usually arises when an unusual cell begins to grow up in the thyroid gland, liable for the secretion of thyroid hormones. This gland is typically found in the front of the neck. This cancer is extremely infrequent among the people. To precisely treat and diagnose thyroid cancer, healthcare professional generally reviews the entire medical history of a patient suffering from this cancer. However, this cancer might reoccur even after many years of the treatment, thus accurate diagnosis of thyroid cancer is required, which may contribute to the market growth around the world. Furthermore, the rise in the prevalence of thyroid cancer, along with the advancements & innovation in diagnosis technology are the few factors responsible for the CAGR of the market during the forecast period. For instance, as per the National Institute of Health (NIH), the rate of new cases of thyroid cancer is estimated at around 15.7 per 100,000 women and men each year. Also, the death rate estimated almost 0.5 per 100,000 women and men every year. Similarly, according to the American Cancer Society, about 52,890 new cases of thyroid cancer were estimated in 2020, of which nearly 41,170 in women and 12,720 in men. This, in turn, is expected to strengthen the need for thyroid cancer diagnostics, making a significant impact on the market growth all over the world. However, the high cost of diagnosis coupled with adverse effects of diagnosis are the few major factors inhibiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global Thyroid Cancer Diagnostic market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing awareness among individuals and reimbursement policies, and the large presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the growing prevalence of thyroid cancer along with the improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the Thyroid Cancer Diagnostic market across the Asia-Pacific region.

Major market player included in this report are:
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Thermo Fisher Scientific, Inc.
General Electric
Siemens Healthcare GmbH
Bio-Rad Laboratories, Inc.
Toshiba Corporation
Koninklijke Philips N.V.
Agilent Technologies, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Papillary carcinoma
Follicular carcinoma
Others

By Technique:
Blood test
Imaging
Biopsy
Others

By End-Use:
Hospital laboratories
Cancer diagnostic centers
Research institutes

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Thyroid Cancer Diagnostic Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…